Disturbance and avoidance of specific consequences of climate change in patients and tourists.

<p>Left: Degree of disturbance. Rating: 1- not disturbing, 2- rather disturbing, 3- disturbing, 4 absolutely disturbing. Right: Avoidance. Rating: 1- not avoid, 2- avoid. The item extreme weather events include thunderstorms, gale storms and heavy rain, but not heat days. * p<0.05, ** p<0.01, *** p<0.001 significant differences between patients and tourists by Kruskal-Wallis-Test.</p

Disturbance and avoidance of specific consequences of climate change in patients classified according to underlying lung disease, allergy and allergic rhinitis.

<p>Left: Degree of disturbance. Rating: 1- not disturbing, 2- rather disturbing, 3- disturbing, 4 absolutely disturbing. Right: Avoidance. Rating: 1- not avoid, 2- avoid. The item extreme weather events include thunderstorms, gale storms and heavy rain, but not heat days. * p<0.05, ** p<0.01, *** p<0.001 significant differences between categories (Asthma vs COPD^#, Allergie vs No Allergy, Allergic rhinitis vs No allergic rhinitis) by Kruskal-Wallis-Test. ^# COPD group includes patients who stated COPD or COPD+Asthma as diagnoses.</p

Characteristics of patients and tourists.

<p>Characteristics of patients and tourists.</p

Correlation of parameters with patients’ perception of being affected by climate change at present and in the future.

<p>Correlation of parameters with patients’ perception of being affected by climate change at present and in the future.</p

General perception of being affected by climate change in patients with lung disease and tourists without lung disease at present and in the future.

<p>Both groups anticipated to be significantly more affected in the future than at present (Fisher’s Exact test, p<0.001). In the future tourists feel more affected than patients (Fisher’s Exact test, p<0.001).</p

Additional file 1 of Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

Supplementary Materials 1

sj-docx-2-tar-10.1177_17534666221148663 – Supplemental material for Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality

Supplemental material, sj-docx-2-tar-10.1177_17534666221148663 for Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality by Kathrin Kahnert, Rudolf A. Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C. Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus F. Rabe, Tobias Welte, Claus F. Vogelmeier and Jürgen Biederer in Therapeutic Advances in Respiratory Disease</p

sj-pdf-1-tar-10.1177_17534666221148663 – Supplemental material for Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality

Supplemental material, sj-pdf-1-tar-10.1177_17534666221148663 for Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality by Kathrin Kahnert, Rudolf A. Jörres, Hans-Ulrich Kauczor, Peter Alter, Franziska C. Trudzinski, Felix Herth, Bertram Jobst, Oliver Weinheimer, Sebastian Nauck, Pontus Mertsch, Diego Kauffmann-Guerrero, Jürgen Behr, Robert Bals, Henrik Watz, Klaus F. Rabe, Tobias Welte, Claus F. Vogelmeier and Jürgen Biederer in Therapeutic Advances in Respiratory Disease</p